$PAND +133% today an acquisition news

$PAND who is a clinical stage biopharmaceutical company developing novel therapeutics designed to address the unmet needs of patients suffering from autoimmune diseases just today after Merck & Co ($MRK) offer $60 per share in cash.

Here is the link of the press release.

Here is the graph of the day.

 

Here is the 30-day overview.

You May Also Like

$GTII the +140% of friday

$ COSM + 72% and bring with him $AMIH for a + 166%

$SWVL + 115% on the day on NO NEWS.

$ICCM + 177% today

Leave a Reply

Your email address will not be published. Required fields are marked *

EMAIL SIGNUP